O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radio
about
Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature reviewPolymeric drug delivery for the treatment of glioblastomaPolifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapyTransfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agentsBCNU/PLGA microspheres: a promising strategy for the treatment of gliomas in mice.Feasibility evaluation of hypofractionated radiotherapy with concurrent temozolomide in elderly patients with glioblastoma.The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide.MGMT promoter methylation correlates with an overall survival benefit in Chinese high-grade glioblastoma patients treated with radiotherapy and alkylating agent-based chemotherapy: a single-institution study.Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).Intracranial microcapsule chemotherapy delivery for the localized treatment of rodent metastatic breast adenocarcinoma in the brain.The future of high-grade glioma: Where we are and where are we going.Extracellular RNAs: development as biomarkers of human disease.O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomasThe prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials.Ribozyme-Spherical Nucleic AcidsRapid regression of glioblastoma following carmustine wafer implantation: A case reportThe combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience.The role of Gliadel wafers in the treatment of high-grade gliomas.Pharmacologic therapies for malignant glioma: a guide for clinicians.Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.Molecularly based management of gliomas in clinical practice.ExRNA in Biofluids as Biomarkers for Brain Tumors.Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up.Combining intraoperative carmustine wafers and Stupp regimen in multimodal first-line treatment of primary glioblastomas.Dual bioluminescence and near-infrared fluorescence monitoring to evaluate spherical nucleic acid nanoconjugate activity in vivo.Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis.MGMT promoter methylation in non-neoplastic brain.MGMT promoter methylation in plasma of glioma patients receiving temozolomide.Prognosis of glioblastoma with faint MGMT methylation-specific PCR product.The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis.Players of 'hypoxia orchestra' - what is the role of FMISO?Immunohistochemical evaluation of O6 -methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma.
P2860
Q26739012-25B57B67-E681-463B-AD34-1C8C89573995Q27010046-6C2EEC30-A758-4F07-A3C3-79377A0DE1C2Q28078486-806BE88A-2A03-4761-8B20-496577625C47Q28273012-1B277A6E-24D0-4D7C-9ADE-563F23D9A1B6Q30782637-6CDB5257-4E20-47E7-A878-9B48333AC4D8Q33433682-20BE7F3E-80DB-4840-BA97-1E716EDD6315Q33578787-2BFF1687-47E5-4516-A8AE-C77C6DDA1CC2Q34166477-70CEDD2A-9049-4212-9C1D-40C2D554097DQ34478948-F84C2338-5395-4B15-8152-BF8340590A1DQ34525981-CD1B042C-92AB-45B6-A6A3-AB64A6568D19Q35114090-F0256B40-AC66-42CD-A38D-CF28A1FDB7F1Q36006446-38CD4830-80BC-4A27-BFA1-14CA25F4BEC4Q36288503-2A572862-54B0-40DA-9ADB-1298130B92A9Q36299167-5008145C-72E8-4CA2-9BB5-3BB216F00D2FQ36338490-8ED92208-732C-448A-B5CD-D7A122464BE4Q37001342-B4992936-E102-4327-8BDC-48B74A7F1B11Q38093776-89E6C933-D778-4AE0-B389-3D62C93DEA4EQ38162925-CBA0FB3C-1951-47EB-A6CE-6EABEE5294E0Q38268897-943A02D1-895D-46BA-8189-618FCC5FC9AAQ38411351-5D92E8A4-FB3D-46E3-A2D0-7865FC9874EDQ38546470-6B617FD6-2971-47CA-95B2-1AD601960BBFQ38551010-FD9B5E35-EB89-4E01-B5F0-223FDA942F8DQ38781031-9F07E91B-2D0A-4059-943B-8AE82EFD4F5EQ39046974-3BB79D46-89C8-4355-95FF-FC88CE450EA5Q39273311-F7F4BAF8-2516-436D-9D56-737FDE469618Q41459741-F99F8381-FC6E-40B0-9DC2-C5796EBDDFB8Q42290698-BC4B088B-73D7-492B-A76F-631353CA75D9Q42364418-D7F6C2B7-1889-466F-AF49-6BBA969FF48DQ44440342-4C4D3C45-C86F-415B-B43C-71D2879E7274Q45088198-02273898-976A-46F3-99A0-80103CF7E089Q48137109-F3E04BCF-1320-45E3-9549-CCB38FD10320Q52606179-5D834117-35D7-4BEE-BA04-40982C8A463DQ52939507-BA16D78E-7BAC-4259-A49B-D2B8A2069A5EQ55461295-FBE1A765-7761-499B-8FEE-559D386F1D1A
P2860
O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radio
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
O(6) -methylguanine-DNA methyl ...... tial surgery followed by radio
@en
type
label
O(6) -methylguanine-DNA methyl ...... tial surgery followed by radio
@en
prefLabel
O(6) -methylguanine-DNA methyl ...... tial surgery followed by radio
@en
P2093
P2860
P356
P1433
P1476
O(6) -methylguanine-DNA methyl ...... tial surgery followed by radio
@en
P2093
Anne Vital
Audrey Emmanuelle Dugué
Emmanuèle Lechapt-Zalcman
Evelyne Emery
Françoise Chapon
Guénaëlle Levallet
Jean-Sébastien Guillamo
Marie-Danièle Diebold
Philippe Colin
Philippe Peruzzy
P2860
P304
P356
10.1002/CNCR.27441
P407
P577
2012-02-22T00:00:00Z